Table 4:
Nucleotide variation | CAD+ (n=70) | CAD− (n=65) | P-value* | ||
---|---|---|---|---|---|
Single vessel disease | Double vessel disease | Triple vessel disease | |||
A | 12 (17.1 %) | 16 (22.9 %) | 18 (25.7 %) | 54 (83.1 %) | 0.03 |
G | 6 (8.6 %) | 10 (14.3 %) | 8 (11.4 %) | 11 (16.9 %) |
Difference between CAD+ and CAD− group